Press Releases

Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam

Nov 28, 2016 7:00am EST

Recro Pharma Reports Third Quarter 2016 Financial Results

Nov 10, 2016 7:00am EST

Recro Pharma to Present at Upcoming Investor Conferences

Nov 09, 2016 7:00am EST

Recro Pharma Presents Clinical Data at PAINWeek 2016

Sep 07, 2016 4:05pm EDT

Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

Sep 06, 2016 7:00am EDT

Recro Pharma Announces Closing of Public Offering of Common Stock

Aug 19, 2016 10:38am EDT

Recro Pharma Announces Pricing of Public Offering of Common Stock

Aug 16, 2016 9:00am EDT

Recro Pharma Announces Proposed Public Offering of Common Stock

Aug 15, 2016 6:06pm EDT

Recro Pharma Reports Second Quarter 2016 Financial Results

Aug 11, 2016 7:00am EDT

Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam

Jul 26, 2016 4:05pm EDT

1...
7
8
9
10
11
12
13
14
15
16